JP2018148915A5 - - Google Patents

Download PDF

Info

Publication number
JP2018148915A5
JP2018148915A5 JP2018099529A JP2018099529A JP2018148915A5 JP 2018148915 A5 JP2018148915 A5 JP 2018148915A5 JP 2018099529 A JP2018099529 A JP 2018099529A JP 2018099529 A JP2018099529 A JP 2018099529A JP 2018148915 A5 JP2018148915 A5 JP 2018148915A5
Authority
JP
Japan
Prior art keywords
antibody
group
amino acid
acid sequence
sequence selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018099529A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018148915A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018148915A publication Critical patent/JP2018148915A/ja
Publication of JP2018148915A5 publication Critical patent/JP2018148915A5/ja
Pending legal-status Critical Current

Links

JP2018099529A 2014-09-16 2018-05-24 抗vasa抗体、ならびにその産生法および使用法 Pending JP2018148915A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462051130P 2014-09-16 2014-09-16
US62/051,130 2014-09-16
US201462089054P 2014-12-08 2014-12-08
US62/089,054 2014-12-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017511337A Division JP2017532953A (ja) 2014-09-16 2015-09-16 抗vasa抗体、ならびにその産生法および使用法

Publications (2)

Publication Number Publication Date
JP2018148915A JP2018148915A (ja) 2018-09-27
JP2018148915A5 true JP2018148915A5 (cg-RX-API-DMAC7.html) 2018-11-08

Family

ID=55454121

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017511337A Pending JP2017532953A (ja) 2014-09-16 2015-09-16 抗vasa抗体、ならびにその産生法および使用法
JP2018099529A Pending JP2018148915A (ja) 2014-09-16 2018-05-24 抗vasa抗体、ならびにその産生法および使用法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2017511337A Pending JP2017532953A (ja) 2014-09-16 2015-09-16 抗vasa抗体、ならびにその産生法および使用法

Country Status (26)

Country Link
US (4) US9403913B2 (cg-RX-API-DMAC7.html)
EP (1) EP3194448A4 (cg-RX-API-DMAC7.html)
JP (2) JP2017532953A (cg-RX-API-DMAC7.html)
KR (1) KR20170056521A (cg-RX-API-DMAC7.html)
CN (1) CN106573985A (cg-RX-API-DMAC7.html)
AP (1) AP2017009758A0 (cg-RX-API-DMAC7.html)
AU (1) AU2015317813B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017003263A2 (cg-RX-API-DMAC7.html)
CA (1) CA2959179A1 (cg-RX-API-DMAC7.html)
CL (1) CL2017000402A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017001724A2 (cg-RX-API-DMAC7.html)
CR (1) CR20170067A (cg-RX-API-DMAC7.html)
DO (1) DOP2017000050A (cg-RX-API-DMAC7.html)
EA (1) EA201790236A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP17011262A (cg-RX-API-DMAC7.html)
GT (1) GT201700036A (cg-RX-API-DMAC7.html)
IL (1) IL250451A0 (cg-RX-API-DMAC7.html)
MX (1) MX358243B (cg-RX-API-DMAC7.html)
NI (1) NI201700022A (cg-RX-API-DMAC7.html)
PE (1) PE20170667A1 (cg-RX-API-DMAC7.html)
PH (1) PH12017500309A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201701016WA (cg-RX-API-DMAC7.html)
SV (1) SV2017005393A (cg-RX-API-DMAC7.html)
TN (1) TN2017000066A1 (cg-RX-API-DMAC7.html)
TW (1) TW201619194A (cg-RX-API-DMAC7.html)
WO (1) WO2016044436A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2828739T3 (es) 2006-04-07 2021-05-27 Aerpio Pharmaceuticals Inc Anticuerpos que se unen a la proteína tirosina fosfatasa beta humana (HPTP-beta) y sus usos
MX363351B (es) 2011-10-13 2019-03-20 Aerpio Therapeutics Inc Un agente de unión a hptp?-ecd para usarse en el tratamiento de síndrome de fuga vascular.
TN2017000066A1 (en) * 2014-09-16 2018-07-04 Ovascience Inc Anti-vasa antibodies, and methods of production and use thereof.
SG10201912556VA (en) 2016-07-20 2020-02-27 Aerpio Therapeutics Inc HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-ß)
EP3856245A4 (en) 2018-09-24 2022-10-26 EyePoint Pharmaceuticals, Inc. MULTISPECIFIC ANTIBODIES AGAINST HPTP - BETA (VE-PTP) AND VEGF
WO2020102565A2 (en) 2018-11-14 2020-05-22 Flagship Pioneering Innovations V, Inc. Systems and methods for nondestructive testing of gametes
WO2021096829A1 (en) * 2019-11-11 2021-05-20 Vanderbilt University Human monoclonal antibodies to hantavirus and methods of use therefor
CN120405134A (zh) * 2024-01-30 2025-08-01 抟相医药(杭州)有限公司 基于凝聚体荧光漂白恢复技术(Drop-FRAP)的生物大分子相互作用调节剂筛选平台

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039518A1 (en) * 1995-06-05 1996-12-12 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefor
EP1233978A4 (en) * 1999-11-18 2003-07-23 Brigham & Womens Hospital COMPOSITIONS AND METHODS FOR IMPROVED DIAGOSIS AND TREATMENT OF Germ Cell Tumors
US6875854B1 (en) * 1999-11-18 2005-04-05 The Brigham And Women's Hospital, Inc. Compositions and methods for the improved diagnosis and treatment of germ cell tumors
WO2005113752A2 (en) 2004-05-17 2005-12-01 The General Hospital Corporation Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
US7955846B2 (en) 2004-05-17 2011-06-07 The General Hospital Corporation Compositions comprising female germline stem cells and methods of use thereof
AU2005256113B2 (en) * 2004-07-09 2011-02-10 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
JPWO2006067847A1 (ja) * 2004-12-22 2008-06-12 中外製薬株式会社 フコーストランスポーターの機能が阻害された細胞を用いた抗体の作製方法
KR20110055687A (ko) 2008-09-25 2011-05-25 고쿠리츠 다이가쿠 호우징 도쿄 가이요우 다이가쿠 항참치 Vasa 항체
CA2748990A1 (en) * 2008-12-26 2010-07-01 The University Of Tokyo Diagnosis and treatment of cancer using anti-lgr7 antibody
WO2011016238A1 (en) * 2009-08-06 2011-02-10 Immunas Pharma, Inc. Antibodies that specifically bind to a beta oligomers and use thereof
NZ706806A (en) 2011-04-14 2016-12-23 Gen Hospital Corp Compositions and methods for autologous germline mitochondrial energy transfer
EP2726601B1 (en) * 2011-06-29 2018-12-26 The General Hospital Corporation Compositions and methods for enhancing bioenergetic status in female germ cells
US9428575B2 (en) * 2012-12-31 2016-08-30 Development Center For Biotechnology Anti-granulysin antibodies and methods of use thereof
TN2017000066A1 (en) * 2014-09-16 2018-07-04 Ovascience Inc Anti-vasa antibodies, and methods of production and use thereof.
EP3245287A4 (en) * 2015-01-13 2018-06-20 President and Fellows of Harvard College Purification of germ stem cells by targeting mrp9

Similar Documents

Publication Publication Date Title
CN112794899B (zh) 一种抗新型冠状病毒的全人源单克隆中和抗体及其应用
CN107760690A (zh) 一种高通量全人源抗体的制备方法及应用
US20230374115A1 (en) Novel coronavirus rbd specific monoclonal antibody and linear epitope and application thereof
CN116375867A (zh) 抗gprc5d抗体及其应用
CN103396481A (zh) 一种二型登革热病毒ns1蛋白的重链单域抗体及其制备方法和应用
WO2025015726A1 (zh) 抗cd19抗体的抗体、抗cd22抗体的抗体及其应用
CN116813780B (zh) 抗人cd31兔单克隆抗体及其应用
CN111303286B (zh) 一种anti-CD19的全人源抗体或抗体片段及其嵌合抗原受体和应用
CN115819590B (zh) 抗猪红细胞膜抗体的制备及应用
CN115838419A (zh) 抗呼吸道合胞病毒抗体及其相关应用
CN115925909A (zh) 抗呼吸道合胞病毒抗体及其相关应用
JPWO2022045126A5 (cg-RX-API-DMAC7.html)
CN109942702B (zh) 一种人鼠嵌合抗HEV全分子IgG及其应用
CN117126269B (zh) 一种1型人博卡病毒型别特异性抗体及其应用
WO2022037002A1 (zh) 特异性结合糖基化ceacam5的抗体
CN117129675B (zh) 用于人博卡病毒型别特异性检测或诊断的试剂或试剂盒
CN113683692B (zh) SARS-CoV-2 N蛋白抗体及其应用
CN116355094B (zh) 抗小鼠白介素12的单克隆抗体及制备方法
TWI698643B (zh) 用於檢測米田堡血型抗原的抗體及其片段、試劑盒及方法
CN117603348A (zh) 抗新型冠状病毒s蛋白的全人源化抗体及其应用
CN111876476A (zh) 用于扩增马抗体的巢式pcr引物、试剂盒及其应用
TWI804099B (zh) 特異性結合糖基化ceacam5的抗體及其製備方法
CN117126270B (zh) 一种2型人博卡病毒型别特异性抗体及其应用
CN118307667A (zh) 一种抗呼吸道合胞病毒的抗体及其用途
US10995134B2 (en) Method for development of monoclonal antibodies